Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook



 

Stem cell and gene therapy heart attack therapy trials begin

09 September 2013

By Siobhan Chan

Appeared in BioNews 721

The first patients from two separate ongoing studies have been treated using gene and stem cell therapies to repair damage caused by heart attacks.

Canadian researchers are trialling a technique that uses genetically enhanced stem cells. Taking a blood sample from patients soon after a heart attack, they can harvest cells known as endothelial progenitor cells that have the ability to form new blood vessels. These are then injected into the heart, where it is hoped they will help muscle to regenerate.

However, cells from patients with heart disease may not be as effective at forming new tissue, so the team plans to add a gene that stimulates blood vessel growth and improves tissue healing, known as endothelial nitric oxide synthase.

'Our strategy is to rejuvenate these stem cells by providing extra copies of a gene that is essential for their regenerative activity, so that they better stimulate heart repair, reduce scar tissue and restore the heart's ability to pump blood efficiently - in other words to help the heart fix itself', said Dr Duncan Stewart, lead investigator of the trial at the Ottawa Hospital Research Institute.

The first patient to be treated on the Canadian trial is 68-year-old Harriet Garrow, who suffered a heart attack in July 2013. Garrow received one of three treatments as part of the randomised double-blind trial – either normal stem cells, genetically enhanced stem cells, or a placebo injection of her own blood plasma. She told the Huffington Post: 'I feel really good. I get better every day, stronger'.

In the UK, another trial reported in BioNews 703 has begun testing in patients. Researchers at Imperial College London will deliver the SERCA2 gene into people with heart failure using a carrier virus. The gene expresses a protein involved in calcium signalling, which allows the heart to pump more effectively.

Dr Alexander Lyon, consultant cardiologist at Royal Brompton Hospital, told the BBC: 'Importantly, early trials suggest the treatment is safe. But we need this large study before we can be sure the gene therapy really works. If we could find an effective treatment, that would be very exciting'.

The Canadian trial will last a further two years, with the trial in the UK due to end in three years.

SOURCES & REFERENCES
Ottawa Hospital Research Institute (press release) | 05 September 2013
 
Huffington Post | 05 September 2013
 
BBC News | 05 September 2013
 
The Globe and Mail | 05 September 2013
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

18 August 2014 - by Isobel Steer 
A gene therapy trial has been launched to help people with advanced heart failure who must constantly carry a bulky battery to power an artificial heart pump....
16 June 2014 - by Dr Kimberley Bryon-Dodd 
Genes linked to cholesterol levels have been successfully edited in mice who received a single injection, thereby reducing their risk of heart disease, according to a study...
12 May 2014 - by Dr Greg Ball 
Two major reviews of clinical trials using stem cells to treat advanced heart disease have found a positive effect of the stem cell treatment, but caution against overstating this effect until more trials are carried out...
06 May 2014 - by Dr Rachael Panizzo 
Heart cells derived from human embryonic stem cells are capable of regenerating damaged heart muscle in primates, a US study has found...
03 February 2014 - by Dr Lanay Griessner 
Stem cells have been created from mouse blood cells using a simple and quick method described as 'remarkable' by experts...

27 August 2013 - by Lanay Tierney 
Researchers have concocted a 'gene cocktail' that may help to turn scar tissue into functioning cardiac cells after a heart attack...
19 August 2013 - by Dr Katie Howe 
A mouse heart was able to contract again after its own cells were removed and replaced with human stem cells, a study in Nature Communications reports...
07 May 2013 - by Siobhan Chan 
Gene therapy will be used to treat heart failure for the first time in the UK, in clinical trials being launched by the British Heart Foundation...
22 April 2013 - by Emma Stoye 
Researchers have identified a gene that regulates the regeneration of adult heart cells...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation